This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe

€600 savings expire in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

Rainer Strohmenger
Managing Partner at Wellington Partners
Speaker

Profile

Dr Rainer Strohmenger joined Wellington Partners in 1997 and became a Partner in 2000 with responsibility for the Life Science portfolio. During his 27 years in venture capital, he has been responsible for the financing of more than 30 portfolio companies, 7 of which were taken public (including Actelion, Oxford Immunotec and immatics), and 9 were successfully exited through trade sales (incl. MTM Laboratories acquired by Roche, Definiens acquired by AstraZeneca, invendo medical acquired by Ambu).

Dr Strohmenger represents Wellington on the boards of its portfolio companies Adrenomed (Berlin), AMB (Waghäusel/Heidelberg), Aignostics (Berlin), Amboss (Berlin), eGenesis (Boston/board observer), iOmx (Munich), Koa Health (Amsterdam/Barcelona), Quanta (Birmingham) and SphingoTec (Berlin).

Prior to joining Wellington, Dr Strohmenger was involved in research work in the fields of cardiovascular physiology and health economics. He holds a Doctor of Medicine and a Master of Economics degree, both from Ludwig-Maximilians-University, Munich (Germany), and was trained at the Entrepreneurship Center of MIT, Boston (USA).

Dr Strohmenger is a Honorary Senator of the German Association of Small and Medium-sized Businesses (BVMW) and served as a Member of the Venture Capital Council at InvestEurope.

Agenda Sessions

  • A day in the life of an experienced dealmaker

    13:00